Drugs Affecting ANS Flashcards
Adrenergic Agonist
Branches of the ANS
Know clonidine (Catapres)
MOA:* MOA: activation of central alpha2 receptors results in inhibition of cardioacceleration &
vasoconstriction centers in the brain
* Leads to decreased outflow of norepinephrine
* Leading to decreases in peripheral resistance, renal vascular resistance, HR & BP by reducing sympathetic function
* Can lead to compensatory effect of retaining sodium (expand blood volume)
* Thus, sometimes given with diuretic
Contraindications for clonidine
severe coronary insuf, recent MI, renal function impairment
* Avoid clonidine if risk of depression
Alpha 2 Agonists - Methyldopa (Aldomet) recommendations
pregnant women
breastfeeding women
Children <12
methyldopa special requirements
LFT
hemolytic anemia
doxazosin (Cardura)
terazosin (Hytrin)
Selective Alpha 1 Antagonist
MOA: blocks alpha 1 receptors in smooth muscle; vasodilates arteries
B. bladder neck and prostate smooth muscle (relieve outflow obstruction)
Selective Alpha 1 Antagonist Adverse Effects
Orthostatic hypotension - known for first dose effect - give dose at bedtime
-rebound tachycardia
-nasal congestion
-fluid retention
-sexual dysfunction
This class of drug may reduce total cholesterol & tryglycerides and increase HDL; enhance insulin sensitivity; regress LVH
Selective Alpha 1 Antagonists
doxazosin and terazosin
Beta Adrenergic Antagonists
Block sympathetic (adrenergic) response by competing for beta receptors
* ***practically all therapeutic effects result from beta 1 blockade in the
heart. The major consequences/actions of blocking these receptors are:
* 1. decrease HR
* 2. decrease contractility
* 3. decrease velocity of A-V conduction
* Also prevent renin release (less water retention)
Beta 1 Cardioselective drugs
metroprolol (Lopressor)
atenolol (Tenormin)
- Children
Non cardioselective B 1 & 2 drugs
propranolol (Inderal)
- Children
labetolol (Trandate)
- Alpha & Beta blockade
Third Generation Beta Blockers
nebivolol (Bystolic)
* Block beta1 - very cardioselective
* Increases nitric oxide release
* Approved for hypertension
* Less likely to produce
problematic DM effects
carvedilol (Coreg)
* BB noncardioselective
* Vasodilation by alpha blockade
* Approved for CHF, HTN, LV
dysfunction after MI
Beta blocker adverse effects
Beta 1 blockade:
* Bradycardia
* Decreased CO
* Precipitation of CHF (in high doses)
* A-V block
* Rebound cardiac excitation
- Beta 2 blockade:
- Bronchospasm
- Inhibition of glycogenolysis (breakdown of glycogen to glucose)
- Also impaired insulin release
- Fatigue, depression
- Sexual dysfunction/Impotence
BB Teaching points
- Teach patients to monitor:
- pulse daily (call if <50 bpm)
- blood glucose (diaphoresis is not masked)
- BP
- Do NOT abruptly withdraw (decrease by ½ q 4 days)
Angiotensin Converting Enzyme Inhibitors (ACE I)
- Block the enzyme that normally converts
angiotensin I to the potent
vasoconstrictor angiotensin II - By blocking the production of angiotensin
II, the drugs decrease vasoconstriction
and decrease aldosterone production
(thereby reducing retention of sodium
and water) - Reduce both preload and afterload
List ACE I
lisinopril (zestril)
captopril (Capoten)
ACE I uses
HTN
Hypertensive Protienuric Diabetes
- renal protective (slows progression of diabetic nephropathy
Angina and ischemic heart disease
post MI
Heart failture
ACE I Adverse Effects
- Cough
- Angioedema (swelling of face, eyes, lips, tongue)
- Occurs within first dose - 1st month
- Usually within 1st week
- Hyperkalemia
- Caution: renal impairment, salt substitutes, K-supplements, K-sparing diuretics
- Hypotension (dizziness, HA)
- Rash
- Neutropenia
- Renal insufficiency (monitor proteinuria, BUN, Creatinine)
ACE I Absolute Contraindications
Bilateral Renal Artery Stenosis
Angioedema
Pregnancy
NSAIDs reduce hypotensive effect
Angiotensin II Receptor Blockers (ARBs)
Instead of decreasing production of angiotensin II, these drugs compete for receptor sites.
No cough or angioedema
Still contraindicated in pregnancy
Losartan (Cozar)
valsartan (Diovan)
ARBs
Renin Inhibitor
aliskerin (Tekturna)
Direct renin inhibitor: decreases the conversion of
angiotensinogen to angiotensin I
* Plasma renin activity is not increased
* Use: HTN
* Adverse Effects:
* Angioedema, cough
* Hyperkalemia
* Substrate CYP 3A4
* Contraindication: pregnancy
Calcium Channel Blockers MOA
Block the influx of calcium which results in: * 1. relaxes arterial smooth muscle (decrease afterload)
* 2. decreases cardiac contractility (negative inotrope)
* 3. decreases sinoatrial (SA) and atrioventricular (AV) nodal conduction
* ***blocking action of CCBs occurs via different receptors